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PICH is a DNA translocase necessary for the resolu-
tion of ultrafine anaphase DNA bridges and to ensure
the fidelity of chromosomal segregation. Here, we
report the generation of an animal model deficient
for PICH that allowed us to investigate its physiolog-
ical relevance. Pich KO mice lose viability during
embryonic development due to a global accumula-
tion of DNA damage. However, despite the presence
of chromosomal instability, extensive p53 activation,
and increased apoptosis throughout the embryo,
Pich KO embryos survive until day 12.5 of embryonic
development. The absence of p53 failed to improve
the viability of the Pich KO embryos, suggesting
that the observed developmental defects are not
solely due to p53-induced apoptosis. Moreover,
Pich-deficient mouse embryonic fibroblasts exhibit
chromosomal instability and are resistant to
RASV12/E1A-induced transformation. Overall, our
data indicate that PICH is essential to preserve chro-
mosomal integrity in rapidly proliferating cells and is
therefore critical during embryonic development and
tumorigenesis.
INTRODUCTION
Chromosomal stability is challenged each time a cell undergoes
DNA replication and segregates its genetic material to the
daughter cells. Many factors have evolved to safeguard genomic
integrity during these processes and to promote the fidelity of
chromosome transmission. The resolution of interlinked sister
chromatids (e.g., due to unfinished DNA replication, DNA repair
intermediates, DNA catenation) that persist from S phase must
occur before or during the anaphase of mitosis for successful
sister chromatid disjunction to occur (Mankouri et al., 2013). In
rare cases, these sister chromatid entanglements may persist
until late anaphase, whereupon they require several factors for3274 Cell Reports 24, 3274–3284, September 18, 2018 ª 2018 The A
This is an open access article under the CC BY-NC-ND license (http://their resolution. Among these factors is PICH (PLK1-interacting
checkpoint helicase), which, despite its importance in mitosis,
is poorly characterized. PICH, also known as ERCC6L, was
discovered as a PLK1 interacting protein (Baumann et al.,
2007). Based on its protein sequence and the results of small
interfering RNA (siRNA)-mediated depletion experiments, PICH
was initially defined as a DNA helicase and mitotic checkpoint
protein (Baumann et al., 2007). However, subsequent studies re-
vealed that PICH lacks helicase activity and does not regulate
the spindle assembly checkpoint (H€ubner et al., 2010). Instead,
PICH has double-stranded DNA (dsDNA) translocase activity
and binds preferentially to DNA under tension in vitro (Biebricher
et al., 2013).
PICH has an unusual pattern of subcellular localization. It lo-
calizes in the cytosol during interphase and is recruited to chro-
matin after nuclear envelope breakdown in prometaphase.
During anaphase, PICH decorates so-called ultrafine anaphase
DNA bridges (UFBs) (Baumann et al., 2007; Chan et al., 2007).
UFBs cannot be detected with DNA dyes such as DAPI and
lack histones, but they are generally defined by the presence
of PICH along much or all of their length (Baumann et al., 2007;
Chan et al., 2007). These mitotic DNA bridges can be found in
most cells and are thought to consist of unresolved DNA replica-
tion intermediates and DNA catenanes that link the separating
sister chromatids. UFBs usually arise from repetitive sequences
such as telomeres, rDNA, and centromeres, or from common
fragile sites (CFSs) (Nielsen and Hickson, 2016). PICH contrib-
utes to the resolution of UFBs, most likely by stimulating the cat-
alytic activity of the TOP2a topoisomerase (Nielsen et al., 2015;
Rouzeau et al., 2012). As a consequence, the lack of PICH leads
to DNA segregation defects that result in the formation of micro-
nuclei and aneuploidy (Hengeveld et al., 2015; Nielsen et al.,
2015). Nevertheless, PICH is not essential for the viability of
chicken DT40 or human cancer cell lines, although in both cases
its depletion causes extensive genomic instability (Hengeveld
et al., 2015; Nielsen et al., 2015).
Given the mitotic segregation defects observed in PICH-defi-
cient cells, it is likely that PICHdeficiency would have detrimental
consequences in vivo; however, to date, there are no reports of
animal models lacking functional PICH. Here, we have generateduthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Pich KO Leads to Embryonic Lethality in Mice
(A) Gene-targeting strategy for the generation of Pich KO mice (see Experimental Procedures for details). ORF, open reading frame.
(B) Morphology of WT and Pich KO embryos at 10.5–13.5 days post-coitum (DPC). Pich KO embryos are smaller than WT embryos and die at approximately
12.5 DPC.
(legend continued on next page)
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Table 1. Genotypes of Progeny from Pich+/ 3WT Crosses
Male Mice Female Mice
Pich+ Pich Pich+/+ Pich+/
Observed 24 0 132 84
Expected 12a 12a 108 108
aWe stopped genotyping males from this strain after finding that Pich KO
males were not born, while we continued genotyping more females.a Pich knockout (KO) mouse model to investigate the relevance
of PICH at the organismal level in mammals. Our results show
that PICH is essential for embryonic development. Pich KO em-
bryos and Pich KO mouse embryonic fibroblasts (MEFs) show
high levels of genomic instability, which is incompatible with a
sustained viability.
RESULTS
Generation of a Pich Conditional KO Mouse Model
The mouse Pich gene is located on the X chromosome and con-
sists of two exons: a short exon 1 (204 bp) and a long exon 2
(4,039 bp) that encodes most of the protein. To study the conse-
quences of PICH deficiency in vivo, we generated a conditional
Pich KO mouse model in which the deletion of the Pich gene
could be induced by the expression of Cre recombinase. We tar-
geted this locus in mouse embryonic stem cells (mESCs) using a
standard recombination strategy with a targeting construct con-
taining a neomycin cassette for selection and two long homology
arms for efficient recombination. We targeted exon 2 to ensure
that most of the PICH protein-coding region would be excised
upon Lox recombination (Figure 1A). Due to the large size of
exon 2, inserting the LoxP sites in such a way as to flank the
entire length of the exon would compromise the efficiency of
Cre-mediated recombination. Therefore, one LoxP site was
positioned inside the 30 UTR of exon 2 (Figure 1A). Using this
strategy, we successfully generated Pich conditional KO
(PichLox) mESC (Figures S1A and S1B). Following that, we gener-
ated male chimeras by microinjecting PichLox mESC into WT
embryos that were able to transmit the PichLox allele to their
progeny. PichLox males and Pich+/Lox and PichLox/Lox females
were born at expected Mendelian ratios and did not show any
obvious phenotypic abnormalities.
Pich KO Mice Die during Embryonic Development
After removal of the neomycin cassette via a cross with Flippase
mice, Pich+/Lox females were crossed with UQ-CMV-Cre trans-
genic males to generate mice harboring a Pich KO allele. Like
Pich, the UQ-CMV-Cre allele is located on the X chromosome
and was therefore transmitted only to females. The deletion of
the Lox-targeted locus was efficient, and Pich heterozygous
(Het) females were obtained. To generate Pich KO mice, Pich
Het females were crossed with wild-type (WT) males. A total of(C) Quantification of embryo length. Error bars indicate SD; data from at least th
(D) Immunohistochemical staining for PICH in WT, Pich heterozygous (Het), and P
embryos.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S1.
3276 Cell Reports 24, 3274–3284, September 18, 201850% of the male offspring from this breeding would be expected
to be Pich KOs. However, all of the males born were found to be
WT for Pich (Table 1), indicating that PICH is essential for embry-
onic development. More important, Pich Het females were born,
indicating that the Pich KO gene is transmitted to the offspring.
However, Pich Het females were born at sub-Mendelian ratios;
40% of the females were Pich Het, whereas 60% were WT
(Table 1).
To characterize the phenotype of the targeted mice, we exam-
ined embryos obtained from Pich Het females crossed with WT
males at different developmental stages. Pich KOmale embryos
were obtained at 10.5, 11.5, 12.5, and 13.5 days post-coitum
(DPC), although at a lower proportion than expected (Table 2).
These results indicate that most Pich KO embryos lose viability
at or before 13.5 days of embryonic development. It should be
noted that Pich Het female embryos were observed at expected
Mendelian ratios (Table 2). Next, we examined themorphology of
Pich KO embryos. Although Pich KO embryos exhibited normal
gross morphology at 10.5 DPC, they were smaller than their
WT or PichHet counterparts (Figures 1B and 1C). This difference
in size becamemore evident after 11.5 DPC. We did not observe
any obvious tissue-specific alteration, but rather a general devel-
opmental arrest incompatible with viability, which was particu-
larly evident in the few Pich KO embryos found at 12.5 and
13.5 DPC (Figure 1B). At these stages Pich Het embryos were
indistinguishable from WT littermates in terms of size and
morphology.
We confirmed the absence of PICH protein in Pich KO em-
bryos by immunohistochemistry (IHC) (Figure 1D). PICH is
located in the cytosol of cells in interphase, and its presence
on chromatin is restricted to mitosis. As expected, PICH IHC re-
vealed a predominantly cytosolic pattern of PICH localization in
interphase cells. In WT and Het embryos, PICH was detected in
most embryonic tissues (Figures 1D, S1D, S2A, and S3A).
Pich KO Embryos Show a Global Increase in DNA
Damage and Apoptosis
To characterize the phenotype of the Pich KO embryos, we per-
formed IHC analysis for factors involved in genome stabilization
or DNA damage signaling. Because PICH promotes accurate
chromosome segregation, we examined whether the loss of
PICH led to chromosomal instability. We detected an increase
in the proportion of cells that are positive for gH2AX, a marker
of DNA damage, in 10.5 DPC Pich KO embryos (Figures 2A,
2D, and S1E). Evidence of DNA damage was detectable in all
of the tissues in the Pich KO embryos, but it was particularly
evident in some areas, including the embryonic brain. Next, we
assessed whether activation of the DNA damage response in
Pich KO embryos could also lead to p53 stabilization. We
observed a high number of p53 positive cells in PichKOembryos
at day 10.5 DPC and onward (Figures 2B, 2D, S1F, and S2C).
Moreover, we observed an increase in the number of apoptotic
cells in Pich KO embryos, as determined by IHC staining forree embryos per genotype.
ich KO embryos at 10.5 DPC confirms the absence of PICH protein in Pich KO
Table 2. Genotypes of Embryos from Crosses between Pich+/
Females and WT Males
DPC
Male Embryos Female Embryos
Pich+ Pich Pich+/+ Pich+/
10.5 14 6 16 15
11.5 12 9 20 21
12.5 10 4 9 11
13.5 10 2 5 10cleaved caspase-3 (Figures 2C, 2D, S1G, S2D, and S3D). These
data indicate that the lack of PICH gives rise to DNA damage and
p53 activation throughout the whole embryo, which ultimately
leads to increased apoptosis and failure of the embryo to suc-
cessfully complete development.
Pich KO MEF Exhibit Mitotic Defects and Impaired
Proliferative Capacity
To further characterize the cause of embryonic lethality in the
Pich KO mice, we generated MEFs from WT and Pich KO em-
bryos at 10.5 and 11.5 DPC. We confirmed the absence of
PICH expression in the KOMEFs by western blotting (Figure 3A).
Pich KOMEFs proliferated at a lower rate than their WT counter-
parts (Figures 3B, S4A, and S4B) and entered into a senescent
state after only three to four passages in culture, as determined
by senescence-associated beta-galactosidase staining (Figures
3C and 3D). At early passages, Pich KO MEF incorporated
5-ethynyl-20-deoxyuridine (EdU) poorly, indicating a very limited
replicative capacity, and also showed a greater tendency to
accumulate in the G2 cell-cycle phase as compared to WT cells
(Figures 3E and 3F). The loss of PICH resulted in various pheno-
types associated with genome instability, including increased
levels of 53BP1 nuclear foci (Figures 4A and 4B), micronucleus
formation (Figures 4A, 4C, and S4C), and polyploidy (Figures
3E and 3F). These results confirm that PICH-deficient cells
have chromosomal segregation defects that result in the activa-
tion of the DNA damage response (DDR) and a reduction in pro-
liferative capacity.
Pich Heterozygous Females Are Born at Sub-Mendelian
Ratios
As mentioned above, Pich Het females are born at sub-Mende-
lian proportions (Table 1). Of 216 females obtained, 132 wereWT
and 84 were Pich Het. Given that the proportion of Pich Het fe-
male embryos at 12.5 DPC was Mendelian (Table 2) and that
we genotyped these mice at 4 weeks of age, 20% of Pich
Het females died either during the latter stages of embryonic
development or perinatally. We believe that this lethality is
most likely explained by the random X chromosome inactivation
that affects the remaining Pich WT allele. Pich Het embryos
showed a mosaic pattern of PICH expression that was compat-
ible with random chromosome X inactivation (Figures 1D and
S1D). However, we cannot rule out that the Pich gene escapes
from full inactivation, as has been reported for Pich in mESCs
(Marks et al., 2015), and low levels of PICH may still be ex-
pressed in all of the cells. The penetrance of the phenotype
was variable, similar to human X-linked disorders. While 20%of Pich Het females died, the rest were born and did not show
any obvious abnormalities, as reflected in their similar appear-
ance and weight as compared to WT littermates (Figures S4E
and S4F). Pich Het females exhibited reduced fertility and they
produced fewer pups (4.6 ± 2.3) than did WT females (15.8 ±
2.9) during a 14-week period (Figure S4G). Of note, two of the
Pich Het females studied did not produce any viable pups
(Figure S4G).
The Pich Het embryos analyzed at 10.5, 11.5, and 12.5 DPC
were similar in size and morphology to their WT littermates (Fig-
ure 1C). Pich Het MEFs proliferated at a slightly lower rate than
their WT counterparts (Figure 3B). Pich Het MEFs exhibited a
mild but significant increase in the number of 53BP1 foci and
micronuclei as compared to their WT counterparts (Figures 4B
and 4C), indicative of genomic instability.
Loss of p53 Does Not Rescue Pich KO Embryonic
Lethality
We observed increased p53 stabilization in Pich KO embryos
(Figures 2B, S1F, S2C, and S3C). p53 stabilization leads to the
induction of apoptosis and senescence (Haupt et al., 2003; Ita-
hana et al., 2001), which could contribute to the embryonic
lethality that is observed in Pich KO embryos. To investigate
this possibility, we crossed our Pich KO model with Trp53 KO
mice (Jacks et al., 1994). The loss of p53 has been demonstrated
to rescue the lethality of other mousemodels with defective DNA
repair, such as Brca1- and DNA Ligase IV-deficient mice (Frank
et al., 2000; Xu et al., 2001). However, no viable Pich KO mice
were born in the absence of Trp53 or in a Trp53 heterozygous
background (Table 3). In addition, we did not observe a rescue
in the phenotype of Pich KO embryos at 10.5 days of embryonic
development in the absence of Trp53 (Table S1; Figure S5).
These data suggest that p53-dependent apoptosis and senes-
cence are unlikely to be the sole drivers of Pich KO embryonic
lethality.
To further characterize the interaction between these two
genes, we derived WT and Pich KO mESCs from our mouse
model. These cell lines were infected with retroviruses express-
ing either control small hairpin RNA (shRNA) or a previously vali-
dated Trp53 shRNA (Murga et al., 2009) (Figure S6A). We could
not perform these experiments in MEFs due to the reduced pro-
liferative capacity of Pich KO MEFs. The number of cells with
high levels of gH2AX or more than two 53BP1 foci per nucleus
were increased in Pich KO mESCs as compared to WT mESCs.
Both of these phenotypes were slightly increased upon knock-
down of Trp53 (Figures S6B and S6C).
In agreement with the above, rather than providing a rescue,
our data indicate that the proportion of successful viable births
in Pich Het females was further reduced in a Trp53 null back-
ground; only one Pich+/;Trp53/ female was born out of seven
expected (Table 3). This observation suggests that a partial syn-
thetic lethal interaction between these two genes may occur in a
scenario with reduced levels of PICH.
In Silico Analysis of the Impact of PICH Status on Human
Cancer
Given the relevance of PICH during embryonic development,
we wanted to address the potential impact of PICH inCell Reports 24, 3274–3284, September 18, 2018 3277
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Figure 2. Pich KO Embryos Show Increased DNA Damage and Apoptosis as Compared to WT and Heterozygous Embryos
(A–C) Immunohistochemical staining of WT, Pich heterozygous (Het), and Pich KO embryos for gH2AX (A), p53 (B), and cleaved caspase-3 (C) at 10.5 DPC.
(D) Quantification of the number of positive cells for gH2AX, p53, and cleaved caspase-3 in the brains of WT, Pich Het, and Pich KO 10.5 DPC embryos. Data
shown correspond to four to six fields per embryo, counting at least 200 cells per field. For gH2AX, oneWT embryo, two PichHet, and two PichKO embryos were
assessed. For p53 and cleaved caspase-3, two WT, three Pich Het, and three Pich KO embryos were assessed.
Error bars indicate SD. See also Figures S1, S2, and S3.tumorigenesis, which is another scenario of intense cell prolifer-
ation. We used the Xena browser (https://xena.ucsc.edu) and
The Cancer Genome Atlas (TCGA) Pan-Cancer (PANCAN) data-
set to analyze a potential correlation between PICH expression3278 Cell Reports 24, 3274–3284, September 18, 2018levels and the presence of mutations in TP53 and RB1, two of
the tumor suppressor genes involved in cell-cycle regulation
that are most frequently mutated in human cancers. Only trun-
cating mutations (frameshift deletion or insertions and nonsense
Figure 3. Characterization of Pich KO MEFs
(A) Western blotting confirming the absence of PICH protein in extracts from two Pich KOMEF cell lines as compared to WTMEF cell lines. Vinculin was used as
the loading control.
(legend continued on next page)
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mutations) were analyzed to disregard the potential gain of func-
tion mutations. PICH expression was significantly higher in can-
cer patient samples with truncating mutations in TP53 or in RB1
as compared to other samples without mutations in either of
these genes (Figures S7A–S7D). Kaplan-Meier analysis showed
that low PICH expression correlated with a better overall survival
in cancer patients (Figure S7E). In addition, cancer type-specific
survival was analyzed using the Kaplan-Meier Plotter tool
(kmplot.com) (Gyo¨rffy et al., 2010), showing that lower PICH
expression correlates with better overall survival in breast and
lung cancer patients (Figures S7F and S7G).
PICH Is Required for RAS/E1A-Induced MEF
Transformation and Growth
To investigate the requirement for PICH in cellular transformation
in vitro, we performed classical MEF transformation assays by
transducing PichKO andWTMEFswith RASV12/E1A constructs.
This transformation assay combines Ras activation and the ef-
fect of the viral oncoprotein E1A, which overrides the G1/S
checkpoint by sequestering RB1 protein (Bandara and La
Thangue, 1991). We found that Pich KO MEFs were not able to
form colonies following the expression of these proteins (Figures
4D, 4E, and S4D), indicating that RASV12/E1A transformation is
insufficient to override the proliferative defects of Pich KO pri-
mary MEFs. Pich Het MEFs were also refractory to transforma-
tion, giving rise to a fewer number of colonies as compared to
WTMEFs (Figures 4D, 4E, and S4D), despite the fact that primary
PichHetMEFswere only slightly affected in terms of proliferation
as compared toWT counterparts (Figure 3B). These in vitro data,
together with our in silico analyses, suggest that PICH activity is
important to sustain the proliferation of certain types of trans-
formed or cancerous cells.
DISCUSSION
In this study, we report a PICH-deficient mouse model, which
has allowed us to investigate the role of PICH during normal
mammalian development. That Pich is located on the X chromo-
some and has an unusual, two-exon gene structure (with a short
exon 1 and a long exon 2) have probably limited the generation of
genetic models in the past.
Our results reveal that PICH is essential for embryonic devel-
opment. Pich KO embryos exhibit genome instability that leads
to generalized apoptosis, developmental arrest, and embryonic
lethality. This genome instability is observed throughout the
entire embryo. Thus, we believe that PICH function is important
at the cellular level and particularly during embryonic develop-(B) Cell proliferation curve of WT, PichHet, and Pich KO primary MEFs derived fro
WT andPichHetMEFs frompassage one and stopped proliferating after four pass
two replicates per cell line.
(C) Senescence-associated beta-galactosidase (SA-b-gal) staining of WT, Pich H
(D) Quantification of the number of SA-b-gal+ cells. Means and SDs were calcula
(E) DNA replication rate and cell-cycle profile of WT and Pich KOMEFs determine
and polyploid cells in green.
(F) Quantification of DNA replication rate (percentages of EdU incorporating cells)
in (E). Data shown correspond to means and SDs from two WT and two Pich KO
**p% 0.01; ****p% 0.0001.
See also Figure S4.
3280 Cell Reports 24, 3274–3284, September 18, 2018ment, when the rate of cell proliferation is very high. The pene-
trance of the lethal phenotype in the embryos is variable, with
some KO embryos reaching day 13.5 (albeit with evidence of
extensive cell death). A similar variability has been reported for
other models that accumulate genomic instability, such as the
Atr-Seckel (Murga et al., 2009) or Brca1-D11 models (Xu et al.,
2001). We believe that this variability likely reflects a stochastic
degree of DNA damage accumulation and repair.
Pich Het females also exhibited a variable phenotype, ranging
from perinatal lethality to the absence of any obvious defects. In
principle, these Het females should be mosaic for Pich expres-
sion due to the random inactivation of one of the X chromosomes
in female cells. However, and similar to several X-linked disor-
ders, a bias in X chromosome inactivation (i.e., preferentially tar-
geting the KO allele) could occur. We have analyzed PICH
expression in four PichHet embryos, observing amosaic pattern
that is compatible with random inactivation (Figures 1D and
S1D). However, we cannot rule out an incomplete silencing of
theWT Pich gene on the inactivated X chromosome, an observa-
tion that has been reported for Pich in mESCs (Marks et al.,
2015). Further researchwill be required to understand the degree
of Pich inactivation in adult mice and to investigate whether Pich
Het females develop any age-associated phenotypes due to a
progressive accumulation of DNA damage.
Weobservedastabilizationof p53 inPichKOembryos,which is
likely a consequence of the chronic activation of a DDR. In some
mouse models with genomic instability, the activation of p53-
dependent apoptosis and senescence programs accounts for
the lethality observed during embryonic development (Frank
et al., 2000; Xu et al., 2001). However, the inactivation of Trp53
didnot rescue the lethality causedbyPICHdeficiency.Webelieve
that the extensive genomic alterations accumulated during the
first 12 days of embryonic development in Pich KO embryos are
incompatible with viability. Furthermore, this is most likely attrib-
utable to deleterious genome alterations rather than to chronic
DDR activation and the subsequent p53-induced apoptosis.
We investigated the genetic interaction between Pich and
Trp53 in further detail and did not observe a significant rescue
or potentiation of the phenotype of Pich KO embryos at 10.5
DPC in the absence of Trp53.
Of particular interest, we found that Pich Het females were
born at a much-reduced frequency than expected in a Tpr53
null background (only one was found of seven expected), sug-
gesting that a partial synthetic lethal interaction between these
genes may actually occur in a scenario with reduced levels of
PICH. Consistent with this, we have found that PICH expression
is significantly higher in cancer patient samples containing TP53m 11.5 DPC littermate embryos. Pich KOMEFs proliferated at a lower rate than
ages. Data represent means and SDs from two different cell lines per genotype,
et, and Pich KO MEFs.
ted from at least five fields per cell line and two cell lines per genotype.
d by high-content microscopy. S-phase cells are shown in red, G2 cells in blue,
and percentages of G2 cells and polyploid cells from the cellular profiles shown
MEF lines analyzed in technical triplicates.
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Figure 4. Genomic Instability and RASV12/E1A Transformation in Pich KO MEFs
(A) Representative images of immunofluorescence staining for 53BP1 in WT and Pich KO MEFs at early passages. Arrows indicate micronuclei, the number of
which is increased in Pich KO MEFs.
(B) Quantification of cells with 53BP1 foci by high-content microscopy. Data correspond to three WT, one Pich Het, and two Pich KO MEF cell lines. Three wells
were counted per cell line, with >1,000 cells for each three wells combined. Means and SDs are indicated.
(C) Quantification of cells with micronuclei. Images were acquired by an automated microscope and micronuclei were manually scored by two independent
researchers. Data correspond to technical triplicates of three WT, one PichHet, and two Pich KOMEF cell lines, counting three wells per cell line and at least 500
cells per sample. Means and SDs are indicated.
(legend continued on next page)
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Table 3. Genotypes of Pups from Pich+/;Trp53+/ Females and Trp53+/ Males
Male Progeny
Pich+ Pich
Trp53+/+ Trp53+/ Trp53/ Trp53+/+ Trp53+/ Trp53/
Observed 4 26 13 0 0 0
Expected 7 15 7 7 15 7
Female Progeny
Pich+/+ Pich+/
Trp53+/+ Trp53+/ Trp53/ Trp53+/+ Trp53+/ Trp53/
Observed 10 23 8 11 21 1
Expected 7 15 7 7 15 7
See also Table S1 and Figures S5, S6, and S7.truncatingmutations as compared to samples without mutations
in TP53 (Figures S7A and S7B). This correlation is compatible
with the idea that higher PICH expression may be required to
sustain growth in tumors that have lost TP53. Further experi-
mental research will be required to understand the functional
relevance of these correlations. We believe that the Pich Het
mESC is a relevant model for this purpose, particularly using
cell differentiation protocols that promote X chromosome inacti-
vation. In addition, our in silico analyses revealed that lower PICH
expression correlated with an overall better survival across a
wide range of cancer patient samples (TCGA Pan-Cancer
dataset).
In line with the above, we observed that PICH is essential to
sustain proliferation in transformed MEFs. In our studies, the
use of an RasV12/E1A transformation assay combines Ras
pathway activation with the expression of the viral oncoprotein
E1A, which suppresses the G1/S checkpoint by sequestering
RB1. We have also observed a correlation between high PICH
expression levels and the presence of RB1 mutations in human
cancer samples. One plausible explanation for these correlations
is that PICH activity is important for tumors with altered cell-cycle
checkpoints caused by mutations in tumor suppressor genes
such as TP53 and RB1. Recent data derived from the use of
siRNAs and shRNAs against PICH in breast and kidney cancer
cell lines also support the idea that PICH is important for the pro-
liferation of cancerous cells (Pu et al., 2017). Our findings are
consistent with PICH being of critical importance for intense
bouts of cell proliferation such as those during embryonic devel-
opment and cancer. We believe that these findings open new
avenues to investigate whether a strategy based on targeting
PICH could provide a potential benefit for cancer patients.
EXPERIMENTAL PROCEDURES
Mouse Model Generation
The targeting construct for the Pich (Ercc6l) gene was generated by Gene
Bridges (Heidelberg, Germany). It was linearized and incorporated intomESCs(D) RASV12/E1A transformation assay of WT, Pich Het, and Pich KO MEF cell line
Colony formation after seeding infected cells at low density and staining 2 week
(E) Quantification of the number of colonies in (D) and Figure S4D. Means and SD
two MEF lines per genotype.
*p% 0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001.
See also Figure S4.
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for Transgenic Mice at the University of Copenhagen. ESC clones containing
the Pichlox(neo) allele were identified by PCR using primers Pich_F1 and
Pich _R1 (Figures 1A, S1A, and S1B; see also sequences below). The expres-
sion of the allele was confirmed by RT-PCR (Albers et al., 2017) using primers
Pich_F3 and Pich _R3 (data not shown; see also primers below). Pichlox(neo)
ESCswere injected inmousemorulae, which were then transferred to pseudo-
pregnant female mice to generate chimeras. The chimeras were then crossed
with FLP-transgenic females (JAX strain 003800, Jackson Laboratory) (Rodrı´-
guez et al., 2000) and produced Pich+/lox female progeny. We generated
Pich+/ females by crossing Pich+/lox females with UQ-CMV-Cre males (JAX
strain 006054) (Schwenk et al., 1995). The Pich cKO strain has a mixed
129S2;C57BL/6N background. The Trp53 KO strain has been described pre-
viously (JAX strain 002101) (Jacks et al., 1994). Mice were housed at the animal
facility of the Department of Experimental Medicine at the University of Copen-
hagen and the research was monitored by the Institutional Animal Care and
Use Committee. All of the mouse work was performed in compliance with
Danish and European regulations.
Mouse Genotyping
Mice were genotyped using three primers—two surrounding the loxP site in
exon 2 of the Ercc6l gene, Pich_F1 (50-CTATGCCTGATCCTCCCCAG-30)
and Pich_R1 (50-GCTAACAGACAAAATGGCCCT-30 ), and one upstream of
exon 1, Pich_F2 (50-AAAGCCCAACTACAGTGTGG-30) (Figure 1A). A 390-bp
WT fragment and a 495-bp PichLox(neo) fragment were amplified using primers
Pich _F1 and Pich _R1. The Pich KO allele was amplified by the Pich _R1 and
Pich _F2 primer and generated a 220-bp fragment. RT-PCR was performed
using primers Pich_F3 (50-GTCTCCTTTCCTGGGCTCTC-30 0) and Pich_R3
(50-AGGCTACAAGTGCCCAAGAA-30).
Other primers used for genotyping were Cre (gCre5: 50-TGGTTTCCCGCA
GAACCTGAAG-30 and gCre3: 50-GAGCCTGTTTTGCACGTTCACC-30), Flip-
pase (FLP_F: 50-CCCATTCCATGCGGGGTATCG-30 and FLP_R: 50-GCAT
CTGGGAGATCACTGAG-30), Trp53 WT allele (KM057: 50-GTGTTTCATTAG
TTCCCCACCTTGAC-30 and KM058: 50-ATGGGAGGCTGCCAGTCCTAA
CCC-30), and Trp53 KO allele (KM053: 50-GTGGGAGGGACAAAAGTTC
GAGGCC-30 and KM054: 50-TTTACGGAGCCCTGGCGCTCGATG-T-30).
Embryo Characterization
Female mice were sacrificed between 10.5 and 13.5 DPC and embryos were
kept in PBS and dissected. Yolk sac DNA was used for genotyping. Embryos
were genotyped using the Pich_F1, Pich_F2, and Pich_R1 primers described
in Mouse Genotyping. Embryo gender was determined by genomic PCR ofs with pBabe-Ras/E1A vector (left) and empty pBabe vector as control (right).
s later.
s were calculated from three (Ras/E1A) or two (pBabe) technical replicates and
Xist and SRY using the following primers: Xist_F (50-GCTTTGTTTCAGTT
TCTCTGG-30 ), Xist_R (50-ATTCTGGACCTATTGGGA-30), SRY_F (50-GCATT
TATGGTGTGGTCC-30), and SRY_R (50-CCAGTCTTGCCTGTATGTGA-30 ). Im-
ages were taken with an Olympus SC50 camera (Olympus) and a Leica M125
stereomicroscope (Leica Microsystems) before embryo fixation.
Embryos at 10.5 DPC were obtained by in vitro fertilization of oocytes from
superovulated Pich+/;Trp53+/ females with sperm from Trp53+/ males and
transferred to pseudopregnant recipientmothers. These procedureswere per-
formed following CARD/Infrafrontier protocols (https://www.infrafrontier.eu/
knowledgebase/protocols/cryopreservation-protocols).
IHC
The IHC analyses were performed in collaboration with the Histopathology
Core Unit at the Spanish National Cancer Research Centre (CNIO, Madrid,
Spain). Mouse embryos were fixed in 4% neutral buffered formalin (Sigma-
Aldrich), paraffin embedded, and processed according to standard proced-
ures. For different staining methods, slides were deparaffinized in xylene
and samples were rehydrated through graded concentrations of ethanol in
water. Consecutive 3-mm sections were stained with H&E, and for IHC, an
automated immunostaining platform was used (Ventana Discovery XT,
Roche Diagnostics, or Autostainer Link, Dako). Antigen retrieval was
performed with high or low (CC1m or RibCC, Roche; PICH, Dako) pH buffer,
depending on the primary antibody, and endogenous peroxidase was
blocked using 3% hydrogen peroxide. The primary antibodies used were
gH2AX (JBV301; 1/25,000; MilliporeSigma, 05-636), p53 (POE316; 1/100;
Monoclonal Core Unit CNIO, AM [POE316]), cleaved caspase-3 (1/750;
Cell Signaling Technology, 9661) and PICH (D4G8; 1/50; Cell Signaling Tech-
nology, 8886). IHC reaction was developed using 3,30-diaminobenzidine
tetrahydrochloride (DAB) (Chromomap DAB, Ventana, Roche; DAB+
Chromogen System, Dako). Nuclei were counterstained with Carazzi’s
hematoxylin. Images were acquired using a slide scanner (AxioScan Z1,
Zeiss).
MEF Generation and Cell Culture
MEFs were obtained from 11.5 or 12.5 DPC embryos following standard pro-
cedures and cultured in DMEM (GIBCO) supplemented with 15% fetal bovine
serum (FBS) and 1% penicillin-streptomycin. For the proliferation assay,
200,000 (Figures 3B and S4B) or 100,000 cells (Figure S4A) were plated in a
well of a 6-well plate. Every 3 to 4 days, cells were counted and replated at
a density of 200,000 cells/well (Figures 3B and S4B) or 100,000 cells/well (Fig-
ure S4A). MEFs were stained at passage seven for senescence-associated
beta-galactosidase (SA-b-gal) using the Senescence Cells Histochemical
Staining Kit (Sigma-Aldrich CS0030).
Immunofluorescence and High-Content Microscopy
MEFs and mESCs were grown in mCLEAR 96-well plates (Greiner Bio-One) for
2 days, before fixation in 4%paraformaldehyde (PFA) and stained according to
standard procedures. The primary antibodies used were 53BP1 (Novus Bio-
logicals 100-304A2) and gH2AX (MilliporeSigma, 05-636). The DNA replication
rate was determined by EdU incorporation using Click-iT technology following
the manufacturer’s instructions (Life Technologies). Images were acquired
with the ScanR acquisition software (Olympus) controlling a motorized
Olympus IX-81 wide-field microscope and analyzed and quantified with the
ScanR Analysis software.
Western Blotting
MEFs and mESCs were lysed with radioimmunoprecipitation assay (RIPA)
buffer (Sigma-Aldrich) containing phosphatase (Sigma-Aldrich) and protease
inhibitor cocktails (Roche). Membranes were blocked in 5% BSA in PBS
with Tween 20 (PBS-T) for 1 hr before primary antibody incubation for PICH
(1/1,000, Cell Signaling Technology, 8886), p53 (1/1,000, Santa Cruz Labora-
tories sc-393031) or vinculin (1/1,000, Sigma-Aldrich V9264). The secondary
antibody for PICH was goat anti-rabbit immunoglobulin G (IgG) (1/10,000,
Sigma-Aldrich A6667); for p53 and vinculin, it was goat anti-mouse IgG
(1/10,000, Sigma-Aldrich A4416). Images were acquired on an Amersham
Imager 600 (GE Healthcare Life Sciences).MEF Transformation Assay
Early passageMEFswere transducedwith a pBabe-RASv12/E1A retroviral vec-
tor (gift from M. Barbacid, CNIO, Madrid, Spain) or a pBabe empty vector ac-
cording to standard procedures. Two days after transduction, cells were
selected with 2 mg/mL puromycin for 2 days. After selection, 10,000 cells
were seededon10-cmPetri dishesandstainedwith crystal violet after 2weeks.
mESC Transduction
mESCs were obtained from in vitro fertilization of Pich+/ oocytes with WT
spermatocytes, performed at the Core Facility for Transgenic Mice at the Uni-
versity of Copenhagen. For the transduction with retroviral vectors encoding
control and p53 shRNA previously validated (Murga et al., 2009), 300,000 cells
were transduced in suspension with 1 mL retroviral supernatant and 1 mg/mL
polybrene. After selection with 1 mg/mL puromycin, cells were seeded on
gelatin-coated mCLEAR 96-well plates for immunofluorescence and high-con-
tent microscopy (see above).
Statistical Analysis
Statistical significance was determined with the unpaired t test in GraphPad
Prism 7. p values are indicated above the graphs: *p % 0.05; **p % 0.01;
***p% 0.001; ****p% 0.0001.
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